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The intent of this discussion is to focus on some concepts which are 
basic to utilizing benefit-cost analysis. It is not intended to be a sum-
mary of benefit-cost analysis. Rather, in the limited time we have together, 
only the tip of the iceberg can be presented. My purpose is really to wet 
your appetite for benefit-cost analysis. Hopefully, you will learn more of 
the concept and/or feel more need to team up with economists in future re-
search activities. 
Topics to be discussed in this paper are (a) historical perspective on 
benefit-cost analysis and (b) basic issues in assessing costs and benefits. 
An important topic omitted from the discussion is (c) measurement techniques. 
A number of tools are available from statistics, operations research, and 
systems science to assist the analyst in measurement. However, it harJly 
seems appropriate to spend our scarce time on measurement techniques at the 
expense of more fundamental ideas. 
Historical Perspective 
The goal of benefit-cost analysis and economics in general is to provide 
the decision maker with information to assist him in making a choice. The 
analyst uses the implicit assumption that the decision maker is interested in 
improving societal welfare. That is, the analyst is systenatically searching 
an array-of alternative solutions and identifying the benefits as well as the 
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costs of each alternative. The basic notion is that the decision maker wants 
to maximize net benefits to society. That is, the decision maker wants to 
select that alternative with the greatest net benefits as long as these net 
benefits are positive. 
The idea of maximizing net benefits is hardly new. I suppose Eve was 
thinking of maximizing net benefits when she ate the apple. Her only problem 
was that she estimated the costs incorrectly. 
A nineteenth century Frenchman, Jules Dupuit, offered the intellectual 
foundation for much of today's analysis. He recognized the existence of 
something called "consumer surplus" w:1ich is discussed later. The problem 
which Dupuit analyzed was public expenditures and financing of bridges and 
roads. He proposed that the benefits of bridges and roads are not the actual 
receipts generated by tolls, but benefits are the public's willingness to pay. 
The parallel of ~r. Dupuit's problem of valuing bridges to veterinary 
r.edicine's problem of valuing disease control is obvious. You know that control 
of disease is an important proposition. You know disease control benefits 
are more than the price which farmers pay for preventive health care. ~!r. 
Dupuit provided the foundation for theories which support your beliefs about 
the benefits of your programs. 
The first systematic application of benefit-cost analysis to public deci-
sions came in the 1930's. The Flood Control Act of 1936 set forth the standard 
that water project benefits had to be greater than costs. A number of agencies 
including the Army Corps of Engineers, the Department of Interior and the 
U.S. Department of Agriculture began developing methodology for measuring 
costs and benefits. 
In the past four decades benefit-cost analysis has expanded dramatically. 
It reached its zenith in the 1960's in an attempt to evaluate expanding 
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federal programs. In the areas of defense, natural resource policy, and 
domestic programs, relevant policy alternatives were examined by estimating 
to the extent possible, the expected economic costs and benefits. 
Assessing benefits and costs is done in both the public and private 
sector. In the private sector it is referred to as "investment analysis", 
and the objective is quantify the net private gain to the business of a par-
ticular course. In the public sector, the objective is to quantify net 
societal gain of a particular course. ~feasurement concepts used for bene-
fit-cost analysis are quite different from those used in investment analysis. 
Basic Issues In Measuring Benefits And Costs 
An example should help point out the capabilities of benefit-cost analysis. 
Assume that a program to reduce swine tuberculosis is to be evaluated. (This 
example is an actual analysis done by the Animal and Plant Health Inspection 
Service of U.S.D.A.) After considerable effort, the following streams of 
benefits and costs are derived. 
Year 
1 
2 
3 
4 
5 
6 
7 
8 
9 
10 
11 
12 
Sum 
Table 1. Swine tuberculosis control program, 
annual benefits and costs 
Actual Benefits 
($ millions) 
.056 
• 349 
.367 
1.406 
1. 891 
2.317 
2.679 
2.952 
3 .111 
3.099 
2.925 
2. 729 
24.381 
Actual Costs 
($ millions) 
.53 
1.41 
1.66 
1.66 
1.66 
1.66 
1.66 
1. 66 
1.66 
1.66 
1.66 
1. 66 
19.59 
We have skipped over many arduous steps in deriving these costs and 
benefits. There are many important judgements to be made by professionals 
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about future benefits of a program. Also, there might be a great deal of 
statistical finesse used to arrive at the costs and benefits. But we gloss 
over these steps to bring out some important points. 
Time Value of Honey 
First, the time value of money must be considered in adding benefits and 
costs. Using the "Sum" in Table 1 is not the correct estimate of benefits 
and costs. Consider spending $1.66 million in year 3. The question is, 
"What is $1.66 million in three years worth today?" Today, we could invest 
something less than $1.66 million and have it grow to $1.66 million with the 
help of compound interest. 
He use the "present value" concept to estimate today's value of some 
future cost and benefit. The present value of $1 at the end of some selected 
years is shown in Table 2. 
n 
1 
2 
3 
10 
20 
Table 2. Present value of $1 at the end 
of n years at i rate of interest 
i 
.06 .08 
.94 .93 
.89 .86 
.84 .79 
.56 .46 
.31 .21 
.10 
.91 
.83 
.75 
.39 
.15 
What is the present value of $1.66 million in the third year? Well, it 
depends on the interest rate or discount rate. We know that society has 
many other ways to spend scarce capital than on swine tuberculosis control. 
Possibly it means sacrificing an 8 or even 10 percent annual return. Thus, 
. . 
' 
' 
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the correct measure of the programs future benefits and cost would be to con-
vert future benefits and costs into present value measurements (Table 3). 
Year 
(1) 
1 
2 
3 
4 
5 
6 
7 
8 
9 
10 
11 
12 
Sum 
Table 3. Swine tuberculosis control program, annual 
costs and benefits discounted at 8 percent 
Present 
Value 
Of $1 
Benefits Costs 
(2) 
.93 
.86 
.79 
.74 
.68 
.63 
.58 
.54 
.50 
.46 
.43 
.40 
Actual Discounted 
(3) (4)=(2)x(3) 
Actual 
(5) 
Discounted 
(6)=(2)x(6) 
-------------------$ millions---------------~-----
.06 .05 .58 .54 
.35 .30 1.41 1. 21 
• 87 .69 1.66 1. 32 
1.41 1.03 1.66 l.22 
l.89 1. 29 1.66 1.13 
2.32 1.46 1.66 1.05 
2.68 1.56 1.66 .97 
2.95 1-.59 1.66 .90 
3.11 J_. 56 1.66 . 83 
3.10 1.44 1.66 • 77 
2.93 1. 25 1.66 • 71 
2.73 1.08 1.66 .66 
13. 30 11.29 
The program's net benefits total $2.nl million (13.30 - 11.29) if a 
discount rate of 8 percent is applied to the future costs and benefits. The 
progran looks favorable. Of course similar analyses would have to be done 
for other programs to determine if this is the "best" program or merely a 
"good one". 
Choice Criteria 
The previous example illustrated one criterion to evaluate a program--
net present value. A second criterion might be the benefit-cost ratio (B/C) 
where 
B/C present value of economic benefits 
present value of economic costs 
•. • t 
~ 
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From our example in Table 3, 
B/C = 13.30/11.29 = 1.18 
If the ratio is greater than one, project expenditures are judged to be 
worthwhile. If the ratio is equal to one, the project adds nothing to the 
economy. If the ratio is less than one, it detracts from economic well 
being. 
A third criteria of ten presented is the internal rate of return. The 
internal rate of return is that discount rate where the present value of 
future benefits equals the present value of future costs. That is, the net 
present value of all future income flows is exactly zero. In Figure 1, the 
net present value varies as the discount rate varies. At some discount rate 
(19.5 percent), the net present value is zero. If society is to receive 
positive benefits from the program, the internal rate of return should exceed 
society's opportunity cost of capital. 
NET 
PRESENT 
VALUE 
6 
($ MILLION) 4 
-2 
FIGURE 1. NET PRESENT VALUE OF SWINE TJBERCULOSIS 
CONTROL PROGRAM, BY DISCOUNT RATE 
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The immediate question raised by the net present value criterion and 
the internal rate of return criterion is, "What interest rate should be 
used?" If we compute the net present value, some interest rate is needed to 
discount future income flows. After computing the internal rate of return, 
some standard is needed to judge the adequacy internal rate of return. 
Society has many alternatives other than disease control for its 
scarce resources. Funds could be invested in other long term projects, or 
they could be consumed today. They could be either in the private or public 
sector. The most appropriate interest rate is the rate of return earned on 
capital in the private sector. 
There are several reasons for arguing that the discount rate to be 
used on public investments (like disease control) may be lower than the 
rate of return on capital in the private sector. Some have argued that 
private investments are too myopic in nature. They tend to discount the 
welfare of future generations too heavily, as witnessed by man's gluttonous 
consumption of nonrenewable energy stocks. Another argument for having the 
discount rate on public projects below the private sector interest rate is 
that risk is less in public projects. That is, the interest rate in the 
private sector includes some risk of repayment component. Supposedly this 
risk of repayment is substantially lessened in the public sector. However, 
most analyses use the rate of return in the private sector since it most 
nearly reflects society's opportunity cost of capital. 
To summarize the basic considerations in measurement, all costs and 
benefits over the life of the proposed project need to be considered. Three 
criteria are available to determine the adequacy of the proposed project--
net present value, benefit cost ratio and internal rate of return. 
' 
Any of these measures are satisfactory criteria of choice. There are 
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more arguments in favor of using the net present value or benefit cost ratio 
than the internal rate of return. However, these are relatively complex 
technical arguments that are not discussed here. Another often used c;1oice 
criteria is cost effectiveness. Here benefits are considered to be similar 
for a number of alternative programs. Thus, benefits are ignored, and the 
costs of the alternative programs are compared. That program with the 
lowest cost is recognized as the "best" alternative. In many cases, disease 
control programs might be evaluated by cost effectiveness analysis. 
Consumer Surplus 
The most crucial concept in measuring benefits is consumer surplus. 
Consumer surplus is the amount which consumers are "willing to pay" rather 
than the amount they actually pay. Consider the program to control swine 
tuberculosis. Gross benefits might be calculated by simply multiplying 
current market price times the quantity of swine saved or P1 • (A - B) in 
Figure 2. Then net benefits might be calculated by subtracting producer's 
costs and the program cost. This method is conceptually incorrect. 
PR ICE 
PER 
POUND 
FIGURE 2. INCORRECT METHOD OF VALUING 
BENEFITS OF DISEASE CONTROL 
A B 
ESTIMATED NET BENEFITS 
PROGRAM (OST + 
PRODUCERS I COSTS 
Pourms 
. . 
' 
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The demand curve for swine is quite inelastic rather than per:c:ctly 
elastic as depicted in Figure 2. A typical demand curve is illustrated in 
Figure 3 as line D. As swine are saved by a disease control progra=, supply 
increases from s1 to s2 , and quantity supplied to consumers increasc:s from 
A to B. It should be noted that in the long run Pz just covers pro~~cers' 
total costs. It includes no excess profits. Disease control does ~ct help 
producers earn greater profits in the long run! 
FIGURE 3, CORRECT ~ETHOD OF VALUING BENEFITS 
PRICE 
PER 
POUND 
A B POUNDS 
The benefits of a disease control program must consider explicitly the 
slope of demand in computing the net benefits. With more swine prod~ced as 
a result of the disease control progran, prices would drop and bene:it 
consumer.s. 
Elasticity of demand is the econocist's jargon for the slope o: the 
demand curve. Elasticity of demand is defined as: 
percent change in quantity 
percent change in price 
For swine, the elasticity of demand is about -.50 at the farm level. Thus, 
every 1 percent decrease in farm level price brings forth about a .5 percent 
increase in quantity consumed. Consider the impact of a disease control 
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program to increase the quantity of swine. A 1 percent increase in the 
quantity of swine produces about a 2 percent decline in swine prices. 
Thus, a disease control program benefits consumers by the shaded region 
in Figure 3. Prior to the program, they pay relatively high prices. After 
the disease control program, more swine in available at a lower price. :~et 
benefits would equal consumer benefits (shaded area in Figure 3) minus program 
costs. 
Does the producer benefit? In the short run, he might be able to cap-
ture some of this consumer surplus. But in the long run, competitive forces 
in the swine industry assure that any increases in efficiency are translated 
into lower swine prices and no profits accrue to him. Rather consumers 
reap the benefits of the program. 
Animal disease control is not a program to benefit farmers. Rather it 
is a consumer assistance program. Too often we fail to understand the real 
impact of our actions. Our intent is probably to help the animal industry 
by lessening disease losses. However, the nature of the competitive animal 
industry assures t~at our cost reducing innovations are quickly translated 
into lower consumer prices. 
External Effects 
The most of ten committed error in the analysis of animal disease control 
is to omit external effects or ''spillover effects''. External effects are 
those costs or benefits which are not included in the direct economic impacts 
of a decision but have incidental or unintentional effects. The analyst 
investigating disease control needs to be cognizant of any possible external 
effects. Animal and human health have abundant cases of spillover effects. 
For example, consider the control of contagious diseases. The individual 
producer certainly recognizes costs of a disease in his herd. However, he 
. . 
. ' 
• 
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does not recognize the costs which he might impose on neighboring herds if 
the disease spreads to other herds. The treatment which he uses for his own 
herd may be quite different than the treatment to prevent exposure of neigh-
boring herds. Thus, the necessity of public agencies to monitor animal 
health and to take action which is in the best interest of society. 
Public goods are the extreme case of goods with external effects. 
Instead of having soLle effects which spillover, all the effects spillover to 
the public and can not be captured by a firm. lfuen society provides national 
defense or public health services, it is recognized that government must 
supply these services if they are to exist. No producer would provide them 
since he could not capture the benefits. Rather the benefits of defense and 
health spillover to the entire population. Any potential buyer would be 
unwilling to pay anything for defense or public health. Instead he would 
say, "If I pay, someone else will reap the benefits. If I refuse to pay, 
someone else may pay and indirectly benefit me. Thus I'll wait for my 
neighbors to supply the goods.'' Only through collective action can the 
availability of a public good be assured. 
Most goods have some spillover effects, but few are so severe to be 
categorized as public goods. The important point to recognize is that market 
price may be an erroneous indicator of value. For example, the chemical 
manufacturer flushing residuals into the water supply imposes costs on 
others. The price of his product does not adequately reflect society's costs. 
Similarly, the market price of disease prevention is not an adequate measure 
of its value to society. The buyer of health services does not internalize 
the impacts he imposes on others in the community. A good or service with 
external effects is always misjudged by market forces. 
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Income Distribution Impacts 
In the case of spillover effects or public goods, market failure is 
explicitly considered. That is, the counting of society's benefits and 
costs may be quite different than the counting of a firm's benefits and 
costs. When counting society's benefits and costs we are certainly inter-
ested in efficiency. Spillover effects or public goods provides a basis 
for collective action to improve efficiency. 
Our analysis also needs to consider the equity impacts. "Whose ox is 
gored?" is the question that needs to be included in our analysis. For 
example, much of the credit for expanded herd sizes and reduced numbers of 
producers can be taken by disease control. Efficiency may be improved, but 
is income distribution improved? Or is it a case of the large producer now 
being able to crowd out the small producer? There is no way to enter the 
income distribution impacts in the analysis. At least it needs to be con-
sidered as another piece of information which should be supplied to the 
decision maker. 
Summary 
• 
Benefit-cost analysis is a useful tool in analyzing the economic impacts 
of disease control. The purpose is to assist the decision maker in choosing 
between alternatives. However, seldom is it able to quantify all the impacts 
of a decision. Impacts such as income distribution effects and spillover 
effects may be unquantifiable. 
Basic considerations in valuing animal disease control programs include 
(a) the time value of money or discounting, (b) the criteria for choosing 
between alternatives, (c) consumer surplus, (d) external effects, (e) public 
goods, and (f) income distribution impacts. It is my judgement that most of 
the analysis of public disease control programs are incomplete. If economic 
ti • 
' ' • 
.. 
• 
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analysis of alternative programs is done, nany of the benefit-cost concepts 
are neglected. 
How do we improve economic analysis in disease control programs? More 
tean work is needed. The resource economist and the veterinarian or epidem-
iologist should be more willing to link their disciplines. This link has 
been missing in the past as evidenced by the lack of benefit-cost analyses 
in the literature, and the public has borne the cost. 
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